1. AB0220 What Proportion of Patients Fail To Achieve CDAI and SDAI Remission Based on Physician Global Assessment? An Analysis from A Prospective, Observational Registry. (15th July 2016) Authors: Starr, M.; Haraoui, B.; Choquette, D.; Bessette, L.; Chow, A.; Baer, P.; Kapur, S.; Kelsall, J.T.; Teo, M.; Rampakakis, E.; Psaradellis, E.; Nantel, F.; Lehman, A.J.; Osborne, B.; Maslova, K.; Tkaczyk, C.M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry. (10th June 2014) Authors: Choquette, D.; Raynauld, J.-P.; Bessette, L.; Fortin, I.; Haraoui, B.; Pelletier, J.-P.; Remillard, M.-A.; Sauvageau, D.; Villeneuve, E.; Coupal, L. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0288 Safety, effectiveness, work and household productivity of anti-tnf alpha therapy with certolizumab pegol observed in adult rheumatoid arthritis patients in daily practice in canada: first interim analysis of the non-interventional fast can study. (23rd January 2014) Authors: Shaikh, S.; Bensen, W. G.; Chow, A.; Dixit, S.; Fortin, I.; Haraoui, B.; Marina, R. B.; Kayhan, C.; Little, K.; Purcaru, O.; Bessette, L. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0301 SARILUMAB AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 12-WEEK TREATMENT RESULTS FROM A MULTICENTER, OPEN-LABEL, PROSPECTIVE, SINGLE-ARM OBSERVATIONAL STUDY. (2nd June 2020) Authors: Kivitz, A.; Gottenberg, J. E.; Bergman, M.; Iglesias-Rodriguez, M.; St John, G.; Qiu, C.; Van Hoogstraten, H.; Bessette, L. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA ®. (2nd June 2020) Authors: Choquette, D.; Bessette, L.; Choquette Sauvageau, L.; Ferdinand, I.; Haraoui, B.; Massicotte, F.; Pelletier, J. P.; Raynauld, J. P.; Rémillard, M. A.; Sauvageau, D.; Villeneuve, É.; Coupal, L. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0661 Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in A Real-World Setting. (15th July 2016) Authors: Bessette, L.; Kapur, S.; Zummer, M.; Starr, M.; Choquette, D.; Sheriff, M.; Olszynski, W.; Rampakakis, E.; Psaradellis, E.; Osborne, B.; Maslova, K.; Nantel, F.; Lehman, A.J.; Tkaczyk, C.M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0935 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs non-biologic dmards in psoriatic arthritis (COMPLETE-PSA): 12-month effectiveness data. (12th June 2018) Authors: Khraishi, M.; Bessette, L.; Chow, A.; Haraoui, B.; Pavlova, V.; Stewart, J.; Remple, V. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB1040 Comparison of Adherence and Dosing Interval of Subcutaneous anti-TNF Biologics in Inflammatory Arthritis from A Canadian Administrative Database. (15th July 2016) Authors: Bhoi, P.; Bessette, L.; Bell, M.; Tkaczyk, C.; Nantel, F.; Maslova, K. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB1068 Disease Burden of Refractory Gouty Arthritis: A One Year Multinational Prospective Observational Study. (10th June 2014) Authors: Bessette, L.; Lioté, F.; Moragues, C.; Moericke, R.; Zhang, Z.; Lecomte, P.; Ferreira, A.; Kessabi, S.; Tian, H.; Li, L.; Singh, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB1069 Burden of Refractory Gouty Arthritis among Difficult-To-Treat Patients over One Year: Post- HOC Analysis from Motion Observational Study. (10th June 2014) Authors: Bessette, L.; Lioté, F.; Moragues, C.; Moericke, R.; Zhang, Z.; Ferreira, A.; Lecomte, P.; Kessabi, S.; Tian, H.; Li, L.; Singh, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗